Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pandemic Produces New Stimulus To Develop Universal Vaccine, Create Better Defenses Against Flu Mutations Of The Future

This article was originally published in PharmAsia News

Executive Summary

BEIJING - The first pandemic to threaten the planet in decades, by focusing a global spotlight on influenza mutations and on biotech-based defenses, is creating a new stimulus to develop a universal vaccine and to expand the sectors of the worldwide populace - especially in lower-income regions - that are immunized

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel